Recorded: Access recorded version, only for one participant unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Corporate Recorded: Access recorded version, Any number of participants unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Closed-loop CAPA mandates a repeatable, systematic Failure Investigation and Root Cause Analysis.
The FDA has faulted companies repeatedly for failure to identify, systematically investigate, resolve, and then verify/validate and monitor for reslution of the key underlying problem basically an inability to define, locate and resolve the basic problem(s) or root cause(s) using a repeatable system. Consequently, the most important area audited by the FDA is CAPA it assures the FDA that company is in compliance without the Agency constantly auditing it. However, one of the most cited 483 observation is failure to resolve the key underlying problem and close out CAPA documents in a timely manner basically an inability to define, locate and resolve the basic problem(s) or root cause(s). FI and RCA also play a major part in sucessful V&V and other CGMP activities. Regular, defined, systematic use of a few simple but powerful tools can contribute greatly to reduction of product liability, cost reduction efforts, less chance of recalls, and an improved bottom line.
Why you should Attend:
Accurate and thorough Failure Investigation and Root Cause Analysis is a key to sucessful CAPA, validatioin, and other problem solving programs. It is also key to many other important cGMP activities Non-conformance / OOS resolution, Complaint Handling, Adverse Event Reporting and Resolution, other Verification and Validation activities, Audit corrective and preventive actions, et al. Simple tools and work flow are not understood, diseminated, and used, consistently. Flow charts, Cause and Effect Diagrams, the 5 Whys, and other statistical tools will be presented and discussed as simple and effective means to accomplish FI/RCA. A breakdown in FI/RCA results in the product failures, liability issues, scrap / waste / fall off, and needless recalls, which we see listed on the FDA's website daily. Avoid a "shoot from the hip" approach. Define, then attack, and resolve root problems / causes, not just symptoms, using repeatable, systematic, SOP-defined methods as part of a "closed-loop" CAPA system, and basic CGMP compliance.
Areas Covered in the Session:
Subscribe for Compliance Alerts Research Reports Absolutely Free